<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37920267</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Surveillance, epidemiology, and impact of the coronavirus disease 2019 interventions on the incidence of enterovirus infections in Nanchang, China, 2010-2022.</ArticleTitle><Pagination><StartPage>1251683</StartPage><MedlinePgn>1251683</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1251683</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2023.1251683</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Pathogen spectrum of Hand, foot and mouth disease (HFMD) has substantially changed in the past decade in China. Growing evidence has indicated that anti-COVID-19 nonpharmaceutical interventions (NPIs) can support control of various infectious diseases, including intestinal diseases.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this study, HFMD cases were enrolled from sentinel hospitals of Nanchang, Jiangxi province, and enteroviruses were genotyped using specific real time RT-PCR. We systematically characterized the epidemiology of HFMD based on the continuous molecular surveillance and estimated the impact of COVID-19 intervention on HFMD incidence using seasonal autoregressive integrated moving average (ARIMA) models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 10247 HFMD cases were included during 2010-2022, of which 6121 enterovirus (EV)-positive cases (59.7%) were identified by real-time RT-PCR. Over 80% cases were associated with EV-A71 and coxsackievirus A16 (CVA16) during 2010-2012, while the type distribution significantly changed as CVA6 emerged to be dominant, accounting for 22.6%-59.6% during 2013-2022. It was observed that the prevalence patterns of EV-A71 and CVA16 were similar and both of them peaked in the second quarter and then leveled off. However, CVA6 was generally prevalent around the fourth quarter, demonstrating a staggered prevalence during 2010-2019. During the COVID-19 epidemic, the seasonal HFMD epidemic peak was restrained, and the ARIMA analysis indicated that the COVID-19 intervention had mitigated EV transmission during the first COVID-19 outbreak in early 2020. In addition, bivariate Spearman's cross-correlation coefficients were estimated for the major types CVA6, CVA16 and EV-A71. Our analyses indicated the possible existence of correlations among CVA6, CVA16 and EV-A71 prevalence in the epidemiological level.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Taken together, the type distribution of HFMD has substantially changed over the last decade and CVA6 and CVA16 are currently the most predominant types co-circulating in Nanchang. The anti-COVID-19 NPIs significantly reduced the incidence of EV infections.</AbstractText><CopyrightInformation>Copyright © 2023 Zhou, Qian, Zhu, Yi, Tu, Yang, Zhang, Zhang, Xia, Ni, Xu, He and Li.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xianfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cancer Research Center, Jiangxi University of Chinese Medicine, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Chunlong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Laboratory, Third Hospital of Nanchang, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Junling</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanglin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Laboratory, Third Hospital of Nanchang, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Xiansheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Tielong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Life Science, Jiangxi University of Chinese Medicine, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Fenglan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Jiangxi Provincial Health Commission Key Laboratory of Pathogenic Diagnosis and Genomics of Emerging Infectious Diseases, Nanchang Center for Disease Control and Prevention, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARIMA</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HFMD</Keyword><Keyword MajorTopicYN="N">enteroviruses</Keyword><Keyword MajorTopicYN="N">phylogenetic analysis</Keyword><Keyword MajorTopicYN="N">seasonality</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>3</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37920267</ArticleId><ArticleId IdType="pmc">PMC10618362</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2023.1251683</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown B. A., Oberste M. S., Alexander J. P., Kennett M. L., Pallansch M. A. (1999). Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73, 9969–9975. doi: 10.1128/JVI.73.12.9969-9975.1999, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.12.9969-9975.1999</ArticleId><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Yao X. J., Xu S. J., Yang H., Wu C. L., Lu J., et al. . (2019). Molecular surveillance of coxsackievirus A16 reveals the emergence of a new clade in mainland China. Arch. Virol. 164, 867–874. doi: 10.1007/s00705-018-4112-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-018-4112-3</ArticleId><ArticleId IdType="pubmed">30498962</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J. F., Zhang R. S., Ou X. H., Chen F. M., Sun B. C. (2014). The role of enterovirus 71 and coxsackievirus a strains in a large outbreak of hand, foot, and mouth disease in 2012 in Changsha, China. IJID 28, 17–25. doi: 10.1016/j.ijid.2014.07.024, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2014.07.024</ArticleId><ArticleId IdType="pubmed">25236389</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow E. J., Uyeki T. M., Chu H. Y. (2023). The effects of the COVID-19 pandemic on community respiratory virus activity. Nat. Rev. Microbiol. 21, 195–210. doi: 10.1038/s41579-022-00807-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X., Guan W., Guo Y., Yu H., Zhang X., Cheng R., et al. . (2015). A novel recombinant lineage's contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012–2013. Sci. Rep. 5:11700. doi: 10.1038/srep11700, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11700</ArticleId><ArticleId IdType="pmc">PMC4485158</ArticleId><ArticleId IdType="pubmed">26121916</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X., Wan Z., Li Y., Hu Y., Jin X., Zhang C. (2020). National Epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol. Sin. 35, 21–33. doi: 10.1007/s12250-019-00169-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00169-2</ArticleId><ArticleId IdType="pmc">PMC7035399</ArticleId><ArticleId IdType="pubmed">31664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L. D., Hu S. X., Zhang H., Luo K. W., Liu Y. Z., Xu Q. H., et al. . (2014). Correlation analysis of EV71 detection and case severity in hand, foot, and mouth disease in the Hunan Province of China. PLoS One 9:e100003. doi: 10.1371/journal.pone.0100003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0100003</ArticleId><ArticleId IdType="pmc">PMC4062471</ArticleId><ArticleId IdType="pubmed">24941257</ArticleId></ArticleIdList></Reference><Reference><Citation>Gay L., Melenotte C., Lakbar I., Mezouar S., Devaux C., Raoult D., et al. . (2021). Sexual dimorphism and gender in infectious diseases. Front. Immunol. 12:698121. doi: 10.3389/fimmu.2021.698121, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.698121</ArticleId><ArticleId IdType="pmc">PMC8339590</ArticleId><ArticleId IdType="pubmed">34367158</ArticleId></ArticleIdList></Reference><Reference><Citation>He F., Rui J., Deng Z., Zhang Y., Qian K., Zhu C., et al. . (2021). Surveillance, epidemiology and impact of EV-A71 vaccination on hand, foot, and mouth disease in Nanchang, China, 2010–2019. Front. Microbiol. 12:811553. doi: 10.3389/fmicb.2021.811553, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.811553</ArticleId><ArticleId IdType="pmc">PMC8770912</ArticleId><ArticleId IdType="pubmed">35069515</ArticleId></ArticleIdList></Reference><Reference><Citation>Head J. R., Keynan Y. (2019). Early evidence of inactivated enterovirus 71 vaccine impact against hand, foot, and mouth disease in a major center of ongoing transmission in China, 2011–2018: a longitudinal surveillance study. Clin. Infect. Dis. 68, 1432–1433. doi: 10.1093/cid/ciy892, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy892</ArticleId><ArticleId IdType="pmc">PMC7819528</ArticleId><ArticleId IdType="pubmed">31879754</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y.-F., Jia L. P., Yu F. Y., Liu L. Y., Song Q. W., Dong H. J., et al. . (2021). Molecular epidemiology of coxsackievirus A16 circulating in children in Beijing, China from 2010 to 2019. World J. Pediatr. 17, 508–516. doi: 10.1007/s12519-021-00451-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00451-y</ArticleId><ArticleId IdType="pmc">PMC8523403</ArticleId><ArticleId IdType="pubmed">34453285</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji T., Han T., Tan X., Zhu S., Yan D., Yang Q., et al. . (2019). Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosafety Health 1, 32–40. doi: 10.1016/j.bsheal.2019.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsheal.2019.02.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamau E., Nguyen D., Celma C., Blomqvist S., Horby P., Simmonds P., et al. . (2021). Seroprevalence and virologic surveillance of enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017. Emerg. Infect. Dis. 27, 2261–2268. doi: 10.3201/eid2709.204915, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2709.204915</ArticleId><ArticleId IdType="pmc">PMC8386771</ArticleId><ArticleId IdType="pubmed">34423767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanbayashi D., Kaida A., Yamamoto S. P., Hirai Y., Kubo H., Fujimori R., et al. . (2017). Impact of Coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka City, Japan. J. Med. Virol. 89, 2116–2121. doi: 10.1002/jmv.24905, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24905</ArticleId><ArticleId IdType="pubmed">28771766</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Chang Z., Wu P., Liao Q., Liu F., Zheng Y., et al. . (2018). Emerging enteroviruses causing hand, foot and mouth disease, China, 2010–2016. Emerg. Infect. Dis. 24, 1902–1906. doi: 10.3201/eid2410.171953, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2410.171953</ArticleId><ArticleId IdType="pmc">PMC6154135</ArticleId><ArticleId IdType="pubmed">30226172</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu L., Mo Z., Wang X., Xia J., Liang Z., et al. . (2014). An inactivated enterovirus 71 vaccine in healthy children. N. Engl. J. Med. 370, 829–837. doi: 10.1056/NEJMoa1303224, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Zhang M., Feng C., Cong S., Xu D., Sun H., et al. . (2021). Characterization of Coxsackievirus A6 strains isolated from children with hand, foot, and mouth disease. Front. Cell. Infect. Microbiol. 11:700191. doi: 10.3389/fcimb.2021.700191, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.700191</ArticleId><ArticleId IdType="pmc">PMC8418080</ArticleId><ArticleId IdType="pubmed">34490141</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukashev A. N., Vakulenko Y. A., Turbabina N. A., Deviatkin A. A., Drexler J. F. (2018). Molecular epidemiology and phylogenetics of human enteroviruses: is there a forest behind the trees? Rev. Med. Virol. 28:e2002. doi: 10.1002/rmv.2002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2002</ArticleId><ArticleId IdType="pubmed">30069956</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhu L. N. T., Nhan L. N. T., Anh N. T., Hong N. T. T., van H. M. T., Thanh T. T., et al. . (2021). Coxsackievirus A16 in southern Vietnam. Front. Microbiol. 12:689658. doi: 10.3389/fmicb.2021.689658, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.689658</ArticleId><ArticleId IdType="pmc">PMC8265502</ArticleId><ArticleId IdType="pubmed">34248913</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios G., Oberste M. S. (2005). Enteroviruses as agents of emerging infectious diseases. J. Neurovirol. 11, 424–433. doi: 10.1080/13550280591002531, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280591002531</ArticleId><ArticleId IdType="pubmed">16287683</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L., Sun M., Song S., Hu Q., Wang N., Ou G., et al. . (2022). The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-a spatiotemporal perspective in Xi'an, northwestern China. J. Med. Virol. 94, 3121–3132. doi: 10.1002/jmv.27715, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27715</ArticleId><ArticleId IdType="pmc">PMC9088661</ArticleId><ArticleId IdType="pubmed">35277880</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M. J., McMinn P., Ooi M. H. (2010). Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10, 778–790. doi: 10.1016/S1473-3099(10)70194-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Zhang Y., Han Z., Xu W., Xiao J., Wang X., et al. . (2020). Genetic recombination in fast-spreading coxsackievirus A6 variants: a potential role in evolution and pathogenicity. Virus Evol 6:veaa048. doi: 10.1093/ve/veaa048</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veaa048</ArticleId><ArticleId IdType="pmc">PMC8597624</ArticleId><ArticleId IdType="pubmed">34804589</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Zhang Y., Ji T., Gu X., Yang Q., Zhu S., et al. . (2017). Persistent circulation of Coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015. Sci. Rep. 7:5491. doi: 10.1038/s41598-017-05618-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05618-0</ArticleId><ArticleId IdType="pmc">PMC5511160</ArticleId><ArticleId IdType="pubmed">28710474</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J., van den Hengel L. G., Raaben M., Blomen V. A., Carette J. E., Brummelkamp T. R. (2018). KREMEN1 is a host entry receptor for a major Group of Enteroviruses. Cell Host Microbe 23, 636–643.e5. doi: 10.1016/j.chom.2018.03.019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.03.019</ArticleId><ArticleId IdType="pubmed">29681460</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Q., et al. . (2022). Identification of a novel binding inhibitor that blocks the interaction between hSCARB2 and VP1 of enterovirus 71. Cell Insight 1:16. doi: 10.1016/j.cellin.2022.100016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellin.2022.100016</ArticleId><ArticleId IdType="pmc">PMC10120312</ArticleId><ArticleId IdType="pubmed">37193133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomba Ngangas S., Bisseux M., Jugie G., Lambert C., Cohen R., Werner A., et al. . (2022). Coxsackievirus A6 recombinant subclades D3/a and D3/H were predominant in hand-foot-and-mouth disease outbreaks in the paediatric population, France, 2010–2018. Viruses 14:51078. doi: 10.3390/v14051078, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051078</ArticleId><ArticleId IdType="pmc">PMC9144281</ArticleId><ArticleId IdType="pubmed">35632819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S. M., Liu C. C., Tseng H. W., Wang J. R., Huang C. C., Chen Y. J., et al. . (1999). Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29, 184–190. doi: 10.1086/520149, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520149</ArticleId><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Teng Z., Cui X., Li C., Pan H., Zheng Y., et al. . (2018). Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012–2016. Emerg. Microbes Infect. 7:8. doi: 10.1038/s41426-017-0011-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-017-0011-z</ArticleId><ArticleId IdType="pmc">PMC5837173</ArticleId><ArticleId IdType="pubmed">29362406</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Yang X. H., Hu S. Q., Zhan W. L., Zhang C. B., Liu H., et al. . (2020). Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China. BMC Infect. Dis. 20:271. doi: 10.1186/s12879-020-04992-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-04992-x</ArticleId><ArticleId IdType="pmc">PMC7137261</ArticleId><ArticleId IdType="pubmed">32264839</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W., Liao Q., Viboud C., Zhang J., Sun J., Wu J. T., et al. . (2014). Hand, foot, and mouth disease in China, 2008–2012: an epidemiological study. Lancet Infect. Dis. 14, 308–318. doi: 10.1016/S1473-3099(13)70342-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Yu M. (2023). Response to global public health emergency: overview and lessons from Chinese experience against COVID-19. J. Glob. Health 13:3016. doi: 10.7189/jogh.13.03016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.03016</ArticleId><ArticleId IdType="pmc">PMC10062396</ArticleId><ArticleId IdType="pubmed">36995297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Zheng C., Qi H., Chen Y., Ward M. P., Liu F., et al. . (2022). Impact of the coronavirus disease 2019 interventions on the incidence of hand, foot, and mouth disease in mainland China. Lancet Reg Health West Pac 20:100362. doi: 10.1016/j.lanwpc.2021.100362, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100362</ArticleId><ArticleId IdType="pmc">PMC8720138</ArticleId><ArticleId IdType="pubmed">35005671</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Zhu Q., Xia W., He F., Hu M., Ni X., et al. . (2015). Molecular epidemiology of an outbreak of hand, foot, and mouth disease associated with subgenotype C4a of enterovirus A71 in Nanchang, China in 2014. J. Med. Virol. 87, 2154–2158. doi: 10.1002/jmv.24288, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24288</ArticleId><ArticleId IdType="pubmed">26058813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P., Ji W., Li D., Li Z., Chen Y., Dai B., et al. . (2023). Current status of hand-foot-and-mouth disease. J. Biomed. Sci. 30:15. doi: 10.1186/s12929-023-00908-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-023-00908-4</ArticleId><ArticleId IdType="pmc">PMC9951172</ArticleId><ArticleId IdType="pubmed">36829162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>